Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 66,650 clinical trials worldwide
Search
Showing 36101-36150 of 66,650 trials
Active filters:
Status: Recruiting
Clinical Trials (66,650)
NCT06275113
BRING-UP Prevention
N/A
Recruiting
6,000 participants
Started: Sep 15, 2023 · Completed: Jun 30, 2026
3 conditions
1 sponsor
196 locations
NCT05635123
A Cohort Study of Uterine Malignancies
N/A
Recruiting
6,200 participants
Started: Sep 15, 2023 · Completed: Dec 1, 2030
2 conditions
1 sponsor
1 location
NCT05880940
Comparing Different Rehabilitation Exercise Strategies for Improving Arm Recovery After Stroke
NA
Recruiting
60 participants
Started: Sep 15, 2023 · Completed: Aug 31, 2025
1 condition
5 sponsors
3 locations
NCT06016465
Does Nerve Block + Oral Dexamethasone Reduce Recurrence of Headache Within 72 Hrs?
EARLY_PHASE1
Recruiting
84 participants
Started: Sep 15, 2023 · Completed: Jan 30, 2026
1 condition
1 sponsor
1 location
NCT05087680
An Acceptance Based PrEP Intervention to Engage Young Black MSM in the South
NA
Recruiting
66 participants
Started: Sep 14, 2023 · Completed: Dec 1, 2025
1 condition
2 sponsors
1 location
NCT06257628
MACE CDS Software Master Enrollment Protocol
N/A
Recruiting
5,515 participants
Started: Sep 14, 2023 · Completed: Apr 11, 2025
1 condition
1 sponsor
3 locations
NCT06569524
Efficacy and Safety of Recombinant Human FGF21-Fc Fusion Protein for Injection (TQA2225/AP025) in Adult Subjects With Non-alcoholic Steatohepatitis (NASH)
PHASE2
Recruiting
120 participants
Started: Sep 14, 2023 · Completed: Dec 31, 2027
1 condition
1 sponsor
53 locations
NCT06324318
Parenting in 2 Worlds Multisite Trial
PHASE2
Recruiting
1,440 participants
Started: Sep 14, 2023 · Completed: Jun 1, 2028
4 conditions
6 sponsors
4 locations
NCT06158464
The Effectiveness of a Functional Capacity Evaluation Among Persons on Sick Leave or Work Disability
NA
Recruiting
200 participants
Started: Sep 14, 2023 · Completed: Aug 31, 2024
3 conditions
3 sponsors
8 locations
NCT05691504
Testing the Combination of APG-1252 (Pelcitoclax) and Cobimetinib in Recurrent Ovarian and Endometrial Cancers
PHASE1
Recruiting
42 participants
Started: Sep 14, 2023 · Completed: Feb 1, 2027
11 conditions
1 sponsor
6 locations
NCT06016062
A Study of RC148 As a Single Agent and Combination Therapy in Patients with Locally Advanced Unresectable or Metastatic Malignant Solid Tumors
PHASE1/PHASE2
Recruiting
221 participants
Started: Sep 14, 2023 · Completed: Dec 31, 2025
1 condition
1 sponsor
31 locations
NCT05569772
Semaglutide for the Treatment of Glucose Intolerance in Women with Prior Gestational Diabetes
PHASE3
Recruiting
252 participants
Started: Sep 14, 2023 · Completed: Dec 31, 2028
1 condition
14 sponsors
13 locations
NCT06066645
Travoprost Intraocular Implant + iStent Infinite vs. iStent Infinite Alone
PHASE3
Recruiting
150 participants
Started: Sep 14, 2023 · Completed: Nov 30, 2025
1 condition
1 sponsor
1 location
NCT05276219
Optimized Treatment of Pulmonary Edema or Congestion
PHASE4
Recruiting
1,104 participants
Started: Sep 14, 2023 · Completed: Dec 31, 2026
3 conditions
4 sponsors
4 locations
NCT05699226
Amplitude Titration to Improve ECT Clinical Outcomes
NA
Recruiting
50 participants
Started: Sep 14, 2023 · Completed: Jan 30, 2026
3 conditions
2 sponsors
1 location
NCT05872295
IKS014 in Advanced Solid Tumors That Express HER2
PHASE1
Recruiting
165 participants
Started: Sep 14, 2023 · Completed: Sep 30, 2027
3 conditions
1 sponsor
12 locations
NCT06086405
ECMO Braile Biomédica® in COVID-19 Patients
N/A
Recruiting
30 participants
Started: Sep 14, 2023 · Completed: Mar 31, 2024
1 condition
1 sponsor
1 location
NCT05949047
Smartphone-based Cognitive Emotion Regulation Training for Unpaid Primary Caregivers of Persons With Alzheimer's Disease
NA
Recruiting
270 participants
Started: Sep 14, 2023 · Completed: May 31, 2027
6 conditions
2 sponsors
1 location
NCT06401837
Acupressure Therapy on Post-stroke Fatigue, Depression, and Sleep Disturbances in Ischemic Stroke Patients
NA
Recruiting
78 participants
Started: Sep 14, 2023 · Completed: Jul 31, 2025
6 conditions
2 sponsors
2 locations
NCT05641116
Effectiveness of an Intervention Combining Adapted Physical Activity and Therapeutic Education in Patients With Chronic Symptoms Attributed to Lyme Borreliosis.
NA
Recruiting
62 participants
Started: Sep 14, 2023 · Completed: Dec 31, 2027
3 conditions
1 sponsor
2 locations
NCT06193538
The Safety and Effectiveness of NV-A01 in Glioma Patients
PHASE1
Recruiting
15 participants
Started: Sep 14, 2023 · Completed: Jul 31, 2025
1 condition
1 sponsor
1 location
NCT05917405
Study Comparing the Efficacy of 2 RIC Regimens (Clofarabine vs Fludarabine) in Adults With AML Eligible to Allo-SCT
PHASE2
Recruiting
302 participants
Started: Sep 14, 2023 · Completed: Sep 14, 2028
1 condition
1 sponsor
23 locations
NCT06032338
Trial of Direct Home Delivery of Colorectal Cancer Screening Kit Without Pre-ordering
NA
Recruiting
64,000 participants
Started: Sep 14, 2023 · Completed: Nov 14, 2026
1 condition
3 sponsors
1 location
NCT06334445
CARDIOCARE Prospective Clinical Study
N/A
Recruiting
736 participants
Started: Sep 14, 2023 · Completed: Dec 31, 2024
1 condition
1 sponsor
1 location
NCT06182072
ProAgio in Pancreatic Ductal Adenocarcinoma (PDAC)
PHASE1
Recruiting
46 participants
Started: Sep 14, 2023 · Completed: Jun 30, 2028
1 condition
3 sponsors
1 location
NCT06034275
Study of VIP943 in Subjects With Advanced CD123+ Hematologic Malignancies
PHASE1
Recruiting
36 participants
Started: Sep 13, 2023 · Completed: Dec 31, 2025
3 conditions
1 sponsor
5 locations
NCT06075199
Intestinal Metaplasia Cohort for Gastric Cancer Prediction
N/A
Recruiting
1,000 participants
Started: Sep 13, 2023 · Completed: Jun 30, 2033
1 condition
1 sponsor
1 location
NCT06032845
Cryoablation Combined with Tislelizumab Plus Lenvatinib in Previously Treated Solid Tumors (CASTLE-11)
PHASE2
Recruiting
25 participants
Started: Sep 13, 2023 · Completed: Dec 30, 2025
1 condition
1 sponsor
1 location
NCT06266286
EXOPULSE Mollii Suit & Cerebral Palsy
NA
Recruiting
32 participants
Started: Sep 13, 2023 · Completed: Oct 30, 2025
1 condition
1 sponsor
4 locations
NCT06045013
Ultrasound-guided Dextrose Injection Versus Dextrose With Methylprednisolone in Carpal Tunnel Syndrome
PHASE3
Recruiting
70 participants
Started: Sep 13, 2023 · Completed: Aug 30, 2026
1 condition
3 sponsors
1 location
NCT05999214
99mTc-H7ND SPECT/CT Imaging in NSCLC
NA
Recruiting
150 participants
Started: Sep 13, 2023 · Completed: Aug 10, 2026
1 condition
1 sponsor
1 location
NCT06476912
Balance Exercise and Vagus Nerve Stimulation on Weight-shifting Control and Ambulation in Parkinson Disease and Anxiety
NA
Recruiting
94 participants
Started: Sep 13, 2023 · Completed: Jul 31, 2026
1 condition
1 sponsor
1 location
NCT06202209
The Impact of Autonomic Function on Atrial Fibrillation Recurrence After Pulmonary Vein Ablation
N/A
Recruiting
100 participants
Started: Sep 13, 2023 · Completed: Oct 30, 2024
1 condition
3 sponsors
1 location
NCT05520346
Testing a Device for Automatically TRacking Urine and STool in an Inpatient HCT Setting (Project TRUST)
NA
Recruiting
54 participants
Started: Sep 13, 2023 · Completed: Jun 30, 2026
1 condition
1 sponsor
1 location
NCT06590025
Study the Efficacy and Safety of the INtegral Cognitive REMediation Program (INCREM) for Depression
PHASE3
Recruiting
296 participants
Started: Sep 13, 2023 · Completed: Dec 31, 2025
2 conditions
1 sponsor
1 location
NCT06036706
Neurocognitive Impact of Different Irradiation Modalities for Patients With Grade I-II Skull Base Meningioma:
NA
Recruiting
108 participants
Started: Sep 13, 2023 · Completed: Jun 30, 2039
2 conditions
2 sponsors
3 locations
NCT05487807
Adapting and Evaluating a Tobacco Use Cessation Program for People Living With HIV in Uganda and Zambia
PHASE1
Recruiting
800 participants
Started: Sep 13, 2023 · Completed: Aug 31, 2026
2 conditions
2 sponsors
2 locations
NCT06806787
Copeptin and Thirst: Possible Predictive Markers of Effectiveness of Bariatric Surgery?
N/A
Recruiting
30 participants
Started: Sep 13, 2023 · Completed: Mar 14, 2026
1 condition
1 sponsor
1 location
NCT05869955
A Study of CC-97540, CD-19-Targeted Nex-T CAR T Cells, in Participants With Severe, Refractory Autoimmune Diseases (Breakfree-1)
PHASE1
Recruiting
270 participants
Started: Sep 13, 2023 · Completed: Aug 29, 2028
4 conditions
2 sponsors
54 locations
NCT05832086
Intermittent Fasting Using a Fasting-Mimicking Diet to Improve Prostate Cancer Control and Metabolic Outcomes
PHASE2
Recruiting
138 participants
Started: Sep 13, 2023 · Completed: Mar 30, 2029
1 condition
2 sponsors
3 locations
NCT05954442
Everolimus With Investigator's Choice of Chemotherapy in Advanced Triple-Negative Breast Cancer (TNBC) With Luminal Androgen Receptor (LAR) Subtype
PHASE3
Recruiting
203 participants
Started: Sep 13, 2023 · Completed: Aug 31, 2026
3 conditions
1 sponsor
1 location
NCT05991453
Trajectories of Recovery After Intravenous Propofol Versus Inhaled VolatilE Anesthesia Trial
NA
Recruiting
13,000 participants
Started: Sep 13, 2023 · Completed: Jul 31, 2028
8 conditions
3 sponsors
20 locations
NCT05878717
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
PHASE2/PHASE3
Recruiting
300 participants
Started: Sep 13, 2023 · Completed: Jul 12, 2027
2 conditions
1 sponsor
130 locations
NCT06045260
"Receptor Radionuclide Therapy With 177Lu-DOTATOC"
PHASE2
Recruiting
100 participants
Started: Sep 13, 2023 · Completed: Jan 31, 2027
3 conditions
1 sponsor
2 locations
NCT06029049
Comparison of Intubation Conditions During Rapid Sequence Induction Obtained With Modified Time Principal Induction With a Standard Intubation Dose of Rocuronium Versus Succinylcholine
PHASE4
Recruiting
152 participants
Started: Sep 13, 2023 · Completed: Jul 1, 2025
1 condition
1 sponsor
1 location
NCT05650658
Left vs Left Randomized Clinical Trial
NA
Recruiting
2,136 participants
Started: Sep 13, 2023 · Completed: Jun 30, 2029
7 conditions
6 sponsors
71 locations
NCT06104085
99mTc-MY6349 SPECT/CT Imaging in Trop2-positive Triple-negative Breast Cancer
NA
Recruiting
30 participants
Started: Sep 13, 2023 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT06259669
Study to Compare Maternal, Fetal, and Infant Outcomes of Women With Mild to Moderate Atopic Dermatitis Exposed to Ruxolitinib Cream During Pregnancy With an Unexposed Control Population
N/A
Recruiting
958 participants
Started: Sep 13, 2023 · Completed: Aug 1, 2033
2 conditions
1 sponsor
1 location
NCT05377905
Microneedle Array Plus Doxorubicin in Cutaneous Squamous Cell Cancer (cSCC)
PHASE1/PHASE2
Recruiting
48 participants
Started: Sep 13, 2023 · Completed: Dec 31, 2026
2 conditions
2 sponsors
1 location
NCT06121245
The PRO-SOma COla (PROSOCO) Study
NA
Recruiting
11 participants
Started: Sep 13, 2023 · Completed: Feb 29, 2024
1 condition
2 sponsors
2 locations
Previous
1
More pages
720
721
722
723
724
725
726
More pages
1333
Next